102 related articles for article (PubMed ID: 26676956)
1. Introduction of positron emission tomography into the Western Norwegian Health Region: Regional balance in resource utilization from 2009 to 2014.
Stokmo HL; Reitan BC; Johnsen B; Gulati A; Kleven-Madsen N; Adamsen TCH; Biermann M
Clin Physiol Funct Imaging; 2017 Sep; 37(5):512-517. PubMed ID: 26676956
[TBL] [Abstract][Full Text] [Related]
2. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.
Johnsen B; Boye K; Rosendahl K; Biermann M; Trovik C; Aukland SM
Clin Physiol Funct Imaging; 2016 Nov; 36(6):441-446. PubMed ID: 26039107
[TBL] [Abstract][Full Text] [Related]
3. PET-CT in the sub-arctic region of Norway 2010-2013. At the edge of what is possible?
Norum J; Søndergaard U; Traasdahl E; Nieder C; Tollåli G; Andersen G; Sundset R
BMC Med Imaging; 2015 Aug; 15():36. PubMed ID: 26316132
[TBL] [Abstract][Full Text] [Related]
4. [Positron emission tomography 2013 in Germany. Results of the query and current status].
Kotzerke J; Oehme L; Grosse J; Hellwig D;
Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
[TBL] [Abstract][Full Text] [Related]
5. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
6. Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
Healy MA; Yin H; Reddy RM; Wong SL
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26903519
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
8. Early clinical experience and impact of [18F]fluorodeoxyglucose positron emission tomography.
Akpinar AT
Nucl Med Commun; 2006 Apr; 27(4):405. PubMed ID: 16531929
[No Abstract] [Full Text] [Related]
9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
10. Use of standardized patients to assess between-physician variations in resource utilization.
McLeod PJ; Tamblyn RM; Gayton D; Grad R; Snell L; Berkson L; Abrahamowicz M
JAMA; 1997 Oct; 278(14):1164-8. PubMed ID: 9326476
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.
Petersen H; Holdgaard PC; Madsen PH; Knudsen LM; Gad D; Gravergaard AE; Rohde M; Godballe C; Engelmann BE; Bech K; Teilmann-Jørgensen D; Mogensen O; Karstoft J; Johansen J; Christensen JB; Johansen A; Høilund-Carlsen PF;
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):695-706. PubMed ID: 26519292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of new technologies PET/CT nuclear imaging].
Giraldes MR
Acta Med Port; 2010; 23(2):291-310. PubMed ID: 20470481
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer.
You JJ; Wong RK; Darling G; Gulenchyn K; Urbain JL; Evans WK
J Thorac Oncol; 2013 Dec; 8(12):1563-9. PubMed ID: 24389439
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
16. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
17. [(18)F]Fluorodeoxyglucose positron emission tomography-computerized tomography and lung cancer: a significant referral bias exists.
Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; DeCamp MM
Eur J Cardiothorac Surg; 2011 Apr; 39(4):560-4. PubMed ID: 20833060
[TBL] [Abstract][Full Text] [Related]
18. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
[TBL] [Abstract][Full Text] [Related]
19. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract][Full Text] [Related]
20. Cervical spine surgery in the Northern Norway Regional Health Authority area in 2014-18.
Ingebrigtsen T; Guldhaugen KA; Kristiansen JA; Kloster R; Grotle M; Solberg TK
Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
